HuGE Literature Finder
Records
1
-
4
UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. Oncology letters 2016 Nov 12 (5): 4231-4237. Cui Chengxu, Shu Chang, Cao Dandan, Yang Yi, Liu Junbao, Shi Shuping, Shao Zhujun, Wang Nan, Yang Ting, Liang Hao, Zou Shanshan, Hu Songni |
Gly71Arg UGT1A1 polymorphism is associated with breast cancer susceptibility in Han Chinese women. Genetics and molecular research : GMR 2016 15 (3): . Shi J, Li L H, Duan X Y, Liu Q, Sun L L, Tian Y |
UGT1A1 gene polymorphisms and the toxicities of FOLFIRI in Chinese Han patients with gastrointestinal cancer. Anti-cancer agents in medicinal chemistry 2012 Aug . Zhou CF, Ma T, Su Y, Ye ZB, Ji J, Yu YY, Zhang J, Liu BY, Zhu ZG |
Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms. Cancer science 2011 Oct 102 (10): 1868-73. Satoh Taroh, Ura Takashi, Yamada Yasuhide, Yamazaki Kentaro, Tsujinaka Toshimasa, Munakata Masaki, Nishina Tomohiro, Okamura Shu, Esaki Taito, Sasaki Yasutsuna, Koizumi Wasaburo, Kakeji Yoshihiro, Ishizuka Naoki, Hyodo Ichinosuke, Sakata Y |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: